These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7533611)

  • 1. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
    Hu DE; Fan TP
    Br J Pharmacol; 1995 Jan; 114(2):262-8. PubMed ID: 7533611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers.
    Hu DE; Hiley CR; Smither RL; Gresham GA; Fan TP
    Lab Invest; 1995 May; 72(5):601-10. PubMed ID: 7538184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nitric oxide, prostaglandins and tyrosine kinase in vascular endothelial growth factor-induced increase in vascular permeability in mouse skin.
    Fujii E; Irie K; Ohba K; Ogawa A; Yoshioka T; Yamakawa M; Muraki T
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):475-80. PubMed ID: 9349634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
    Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
    Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C inhibitor calphostin C prevents cytokine-induced angiogenesis in the rat.
    Hu DE; Fan TP
    Inflammation; 1995 Feb; 19(1):39-54. PubMed ID: 7535750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants.
    Majima M; Hayashi I; Muramatsu M; Katada J; Yamashina S; Katori M
    Br J Pharmacol; 2000 Jun; 130(3):641-9. PubMed ID: 10821793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action.
    Waltenberger J; Mayr U; Frank H; Hombach V
    J Mol Cell Cardiol; 1996 Jul; 28(7):1523-9. PubMed ID: 8841939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
    Mandriota SJ; Pepper MS
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF(121)- and bFGF-induced increase in collateral blood flow requires normal nitric oxide production.
    Yang HT; Yan Z; Abraham JA; Terjung RL
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1097-104. PubMed ID: 11179052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide suppresses bFGF- and IL-1-alpha-mediated but not VEGF165-mediated angiogenesis in natively vascularized mammalian tissue.
    Norrby K
    APMIS; 1998 Dec; 106(12):1142-8. PubMed ID: 10052722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane.
    Wilting J; Christ B; Bokeloh M; Weich HA
    Cell Tissue Res; 1993 Oct; 274(1):163-72. PubMed ID: 7694800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma.
    Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Hicklin DJ; Huber J; Nakatani T; Tsujinoue H; Yanase K; Imazu H; Fukui H
    Hepatology; 2002 Apr; 35(4):834-42. PubMed ID: 11915029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.
    Hori Y; Hu DE; Yasui K; Smither RL; Gresham GA; Fan TP
    Br J Pharmacol; 1996 Aug; 118(7):1584-91. PubMed ID: 8842418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel in vitro assay for human angiogenesis.
    Brown KJ; Maynes SF; Bezos A; Maguire DJ; Ford MD; Parish CR
    Lab Invest; 1996 Oct; 75(4):539-55. PubMed ID: 8874385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis.
    Tomanek RJ; Sandra A; Zheng W; Brock T; Bjercke RJ; Holifield JS
    Circ Res; 2001 Jun; 88(11):1135-41. PubMed ID: 11397779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of basic fibroblast growth factor-induced angiogenesis by a specific chymase inhibitor, BCEAB, through the chymase-angiotensin-dependent pathway in hamster sponge granulomas.
    Muramatsu M; Yamada M; Takai S; Miyazaki M
    Br J Pharmacol; 2002 Oct; 137(4):554-60. PubMed ID: 12359638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.